nordvacc
Nordvacc is a Swedish veterinary distributor founded in 1983 that markets and distributes vaccines and pharmaceuticals for companion and farm animals across the Nordic region, serving veterinary practitioners and livestock producers.
- Company typePrivate
- Founded1983
- Headquarters—
- Headcount—
- GTM typeB2B
- OfferingServices
What nordvacc does
Nordvacc is a Swedish private company founded in 1983 that markets and distributes veterinary vaccines and pharmaceuticals for both companion animals and farm animals. The company's website is nordvacc.se, indicating a Nordic market orientation. Its business model centers on the wholesale distribution of biological and pharmaceutical products to veterinary practitioners, livestock producers, and other animal health customers, a segment that requires GDP-compliant cold-chain logistics, manufacturer supply agreements, and regulatory product registrations.
The input data provides no further detail on Nordvacc's product portfolio, supplier relationships, headcount, pricing structure, geographic footprint beyond the Nordics, customer mix, or financial performance. The company website returned only a CAPTCHA verification page during data collection, precluding extraction of detailed operational information. No information is available regarding ownership structure, parent company affiliation, funding history, or recent strategic actions.
As a four-decade-old veterinary distribution specialist, Nordvacc likely operates as a niche incumbent in the Nordic animal health market, but the depth of its competitive position, scale, and growth trajectory cannot be assessed from the available data.
nordvacc firmographics
Firmographics- Name
- nordvacc
- Website
- https://nordvacc.se
- Company type
- Private
- Founded year
- 1983
- Short description
- Nordvacc is a Swedish veterinary distributor founded in 1983 that markets and distributes vaccines and pharmaceuticals for companion and farm animals across the Nordic region, serving veterinary practitioners and livestock producers.
- Ownership category
- akta.pro rank
nordvacc industry classification
Industry- Product category
- Veterinary Pharmaceuticals Distribution
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)
- akta.pro secondary industries
- Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Veterinary Distributor Value-Added Services (3PL, Cold Chain, Returns) (HLAMAIAG), Veterinary Vaccines (Biologics) (HLAMAEAL)
Keywords
nordvacc business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales
nordvacc product offering
Product offeringCore offering
Nordvacc markets and distributes veterinary vaccines and pharmaceutical products for companion animals and farm animals. The company operates as a specialized animal-health distributor serving the Nordic market, sourcing veterinary medicines from manufacturers and making them available to veterinary professionals and animal owners/producers.
Differentiator
Problem solved
Functional benefit
Companies that use nordvacc
Customer profileIdeal customer profiles2 records
nordvacc technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
nordvacc competitors and assessment
Company assessmentDirect peers
- HIPRA: Spain-based animal-health company specializing in veterinary vaccines for livestock and aquaculture, with growing companion-animal presence. Comparable as a European vaccine specialist whose distribution strategy in the Nordics would directly affect Nordvacc's competitive position.
- IDT Biologika: German veterinary vaccines and biologics manufacturer with a focus on livestock and zoonotic disease vaccines. Comparable as both a potential upstream supplier to Nordvacc and a competitor in regional European vaccine distribution markets.
Broad incumbents
- Zoetis: Largest global animal-health manufacturer with broad veterinary vaccine and pharmaceutical portfolios across companion and livestock species. Highly comparable because it competes for the same veterinary clinic customers Nordvacc serves and increasingly pursues direct distribution in mature European markets.
- Elanco Animal Health: Global animal-health manufacturer with companion-animal and livestock vaccines and therapeutics. Comparable as both a potential principal supplier and a competitor pursuing direct distribution channels in European veterinary markets.
- Virbac: Global veterinary pharmaceutical company headquartered in France, offering vaccines, parasiticides, and therapeutics primarily for companion animals. Comparable because it addresses the same European veterinary clinic customers and competes for Nordic vaccine share.
- Dechra Pharmaceuticals: UK-based specialist veterinary pharmaceuticals company focused on companion-animal therapeutics and endocrinology. Comparable as a competing supplier of veterinary pharmaceuticals into European veterinary practices, potentially complementing or substituting Nordvacc's product lines.
- Ceva Santé Animale: France-headquartered global animal-health company with a strong focus on veterinary vaccines and pharmaceuticals across companion and livestock species. Comparable as a European regional heavyweight whose products and distribution strategies directly overlap with Nordvacc's footprint.
- Vetoquinol: European-headquartered veterinary pharmaceutical company focused on companion animals and livestock. Comparable as a mid-sized European animal-health player that competes in similar Nordic distribution channels and product categories.
- MSD Animal Health: Animal-health division of Merck offering vaccines, parasiticides, and pharmaceuticals across companion and farm animals. Directly comparable as a principal whose products Nordvacc distributes and which could choose to bypass regional distributors in the Nordics.
- Boehringer Ingelheim Animal Health: Major animal-health manufacturer with a strong veterinary vaccines franchise, particularly for swine and companion animals. Comparable because its biologics portfolio is a likely core of Nordvacc's distributed inventory and it competes for the same Nordic veterinary practice customers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
nordvacc financial estimates
Financial estimateRevenue estimate
Valuation estimate
nordvacc leadership team
Management profileNumber of profiles
nordvacc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
nordvacc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about nordvacc
What does nordvacc do?
Nordvacc markets and distributes veterinary vaccines and pharmaceutical products for companion animals and farm animals. The company operates as a specialized animal-health distributor serving the Nordic market, sourcing veterinary medicines from manufacturers and making them available to veterinary professionals and animal owners/producers.
When was nordvacc founded?
nordvacc was founded in 1983.
Who are nordvacc's main competitors?
Direct peers on record are HIPRA and IDT Biologika. Broad incumbents are Zoetis, Elanco Animal Health, Virbac, Dechra Pharmaceuticals, Ceva Santé Animale, Vetoquinol, MSD Animal Health and Boehringer Ingelheim Animal Health.
Does nordvacc have an API?
No public API is recorded for nordvacc.
What industry is nordvacc in?
nordvacc's product category is Veterinary Pharmaceuticals Distribution. Its primary akta.pro industry code is HLAMAIAA, Veterinary Pharmaceutical Wholesalers & Distributors, with a secondary code of HLAMAIAC, Veterinary Vaccine & Biologics Distributors. Its SIC code is 5122.